Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
Vanguard Dividend Appreciation ETF
VIG
$112B
| $2.09M | ﹤0.01% |
9,700
-6,200
| -39% | -$1.38M |
2025 Q3
2 quarters
|
|
1877
DELISTED
Theravance Biopharma
TBPH
| $2.08M | ﹤0.01% |
+127,916
| New | +$2.26M |
2026 Q1
0 quarters
|
|
1878
EVgo
EVGO
$160M
| $2.05M | ﹤0.01% |
1,192,933
+288,100
| +32% | +$770K |
2025 Q2
3 quarters
|
|
1879
Century Therapeutics
IPSC
$264M
| $2.05M | ﹤0.01% |
906,827
-442,373
| -33% | -$930K |
2022 Q4
13 quarters
|
|
1880
Bitdeer Technologies
BTDR
$2.5B
| $2.05M | ﹤0.01% |
+236,753
| New | +$2.49M |
2026 Q1
0 quarters
|
|
1881
Myriad Genetics
MYGN
$411M
| $2.04M | ﹤0.01% |
454,374
+75,000
| +20% | +$391K |
2024 Q3
6 quarters
|
|
1882
AmeriServ Financial
ASRV
$74.7M
| $2.04M | ﹤0.01% |
564,474
-18,600
| -3% | -$66K |
2013 Q2
51 quarters
|
|
1883
Disc Medicine
IRON
$2.33B
| $2.03M | ﹤0.01% |
31,820
-31,000
| -49% | -$2.15M |
2024 Q4
5 quarters
|
|
1884
Oppenheimer Holdings
OPY
$1.2B
| $2.03M | ﹤0.01% |
22,800
+400
| +2% | +$33.5K |
2016 Q2
39 quarters
|
|
1885
B&G Foods
BGS
$200M
| $2.02M | ﹤0.01% |
420,800
+335,800
| +395% | +$1.63M |
2025 Q4
1 quarter
|
|
1886
Lite Strategy Inc
LITS
$37.1M
| $2.02M | ﹤0.01% |
1,744,700
+203,278
| +13% | +$247K |
2015 Q3
42 quarters
|
|
1887
The Joint Corp
JYNT
$98.2M
| $2.02M | ﹤0.01% |
228,578
-6,800
| -3% | -$61.8K |
2017 Q4
33 quarters
|
|
1888
Eversource Energy
ES
$24.9B
| $2.02M | ﹤0.01% |
+29,180
| New | +$2.06M |
2026 Q1
0 quarters
|
|
1889
Certara
CERT
$1.4B
| $2.02M | ﹤0.01% |
354,500
+324,900
| +1,098% | +$2.48M |
2025 Q2
3 quarters
|
|
1890
Pennant Group
PNTG
$1.41B
| $2.02M | ﹤0.01% |
66,186
-51,514
| -44% | -$1.59M |
2023 Q1
12 quarters
|
|
1891
W&T Offshore
WTI
$566M
| $2.01M | ﹤0.01% |
590,300
+361,900
| +158% | +$895K |
2021 Q1
20 quarters
|
|
1892
Biomea Fusion
BMEA
$99.3M
| $2.01M | ﹤0.01% |
1,312,798
+834,179
| +174% | +$1.1M |
2025 Q3
2 quarters
|
|
1893
Vanguard Total World Stock ETF
VT
$82.6B
| $2.01M | ﹤0.01% |
+14,500
| New | +$2.09M |
2026 Q1
0 quarters
|
|
1894
Ridgepost Capital
RPC
$896M
| $2M | ﹤0.01% |
275,794
+209,994
| +319% | +$1.9M |
2022 Q3
14 quarters
|
|
1895
Rackspace Technology
RXT
$938M
| $2M | ﹤0.01% |
2,041,600
+250,700
| +14% | +$305K |
2022 Q1
16 quarters
|
|
1896
Bloomin' Brands
BLMN
$744M
| $2M | ﹤0.01% |
369,796
+160,942
| +77% | +$1.03M |
2025 Q4
1 quarter
|
|
1897
Bank of N.T. Butterfield & Son
NTB
$2.3B
| $1.99M | ﹤0.01% |
38,000
+24,566
| +183% | +$1.26M |
2025 Q4
1 quarter
|
|
1898
Kayne Anderson BDC
KBDC
$823M
| $1.99M | ﹤0.01% |
145,322
+73,322
| +102% | +$1.03M |
2024 Q3
6 quarters
|
|
1899
Avino Silver & Gold Mines
ASM
$914M
| $1.99M | ﹤0.01% |
+314,900
| New | +$2.52M |
2026 Q1
0 quarters
|
|
1900
Strata Critical Medical Inc
SRTA
$403M
| $1.99M | ﹤0.01% |
474,886
-123,900
| -21% | -$596K |
2022 Q2
15 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.